Literature DB >> 29632069

Extracellular α-synuclein drives sphingosine 1-phosphate receptor subtype 1 out of lipid rafts, leading to impaired inhibitory G-protein signaling.

Shaymaa Mohamed Mohamed Badawy1, Taro Okada1, Taketoshi Kajimoto1, Mitsuhiro Hirase1, Shubi Ambwene Matovelo1, Shunsuke Nakamura1, Daisuke Yoshida1, Takeshi Ijuin1, Shun-Ichi Nakamura2.   

Abstract

α-Synuclein (α-Syn)-positive intracytoplasmic inclusions, known as Lewy bodies, are thought to be involved in the pathogenesis of Lewy body diseases, such as Parkinson's disease (PD). Although growing evidence suggests that cell-to-cell transmission of α-Syn is associated with the progression of PD and that extracellular α-Syn promotes formation of inclusion bodies, its precise mechanism of action in the extracellular space remains unclear. Here, as indicated by both conventional fractionation techniques and FRET-based protein-protein interaction analysis, we demonstrate that extracellular α-Syn causes expulsion of sphingosine 1-phosphate receptor subtype 1 (S1P1R) from the lipid raft fractions. S1P1R regulates vesicular trafficking, and its expulsion involved α-Syn binding to membrane-surface gangliosides. Consequently, the S1P1R became refractory to S1P stimulation required for activating inhibitory G-protein (Gi) in the plasma membranes. Moreover, the extracellular α-Syn also induced uncoupling of the S1P1R on internal vesicles, resulting in the reduced amount of CD63 molecule (CD63) in the lumen of multivesicular endosomes, together with a decrease in CD63 in the released exosomes from α-Syn-treated cells. Furthermore, cholesterol-depleting agent-induced S1P1R expulsion from the rafts also resulted in S1P1R uncoupling. Taken together, these results suggest that extracellular α-Syn-induced expulsion of S1P1R from lipid rafts promotes the uncoupling of S1P1R from Gi, thereby blocking subsequent Gi signals, such as inhibition of cargo sorting into exosomal vesicles in multivesicular endosomes. These findings help shed additional light on PD pathogenesis.
© 2018 Badawy et al.

Entities:  

Keywords:  ganglioside; lipid raft; signal transduction; sphingosine-1-phosphate (S1P); α-synuclein (α-synuclein)

Mesh:

Substances:

Year:  2018        PMID: 29632069      PMCID: PMC5971450          DOI: 10.1074/jbc.RA118.001986

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein.

Authors:  J Y Sung; J Kim; S R Paik; J H Park; Y S Ahn; K C Chung
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

2.  Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.

Authors:  J Fuchs; C Nilsson; J Kachergus; M Munz; E-M Larsson; B Schüle; J W Langston; F A Middleton; O A Ross; M Hulihan; T Gasser; M J Farrer
Journal:  Neurology       Date:  2007-01-24       Impact factor: 9.910

3.  Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes.

Authors:  Taketoshi Kajimoto; Taro Okada; Satoshi Miya; Lifang Zhang; Shun-ichi Nakamura
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

4.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival.

Authors:  Evangelia Emmanouilidou; Katerina Melachroinou; Theodoros Roumeliotis; Spiros D Garbis; Maria Ntzouni; Lukas H Margaritis; Leonidas Stefanis; Kostas Vekrellis
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

6.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal.

Authors:  L Maroteaux; J T Campanelli; R H Scheller
Journal:  J Neurosci       Date:  1988-08       Impact factor: 6.167

7.  Susceptibility of ganglioside GM1 to a new bacterial neuraminidase.

Authors:  K Sugano; M Saito; Y Nagai
Journal:  FEBS Lett       Date:  1978-05-15       Impact factor: 4.124

8.  Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects.

Authors:  R Borghi; R Marchese; A Negro; L Marinelli; G Forloni; D Zaccheo; G Abbruzzese; M Tabaton
Journal:  Neurosci Lett       Date:  2000-06-16       Impact factor: 3.046

9.  Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain.

Authors:  P J Kahle; M Neumann; L Ozmen; V Muller; H Jacobsen; A Schindzielorz; M Okochi; U Leimer; H van Der Putten; A Probst; E Kremmer; H A Kretzschmar; C Haass
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

10.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

View more
  11 in total

Review 1.  Glycoconjugate journal special issue on: the glycobiology of Parkinson's disease.

Authors:  Inka Brockhausen; John Schutzbach; Jiabei Wang; Beth Fishwick; Jennifer Brockhausen
Journal:  Glycoconj J       Date:  2021-11-10       Impact factor: 2.916

2.  Differential Aggregation and Phosphorylation of Alpha Synuclein in Membrane Compartments Associated With Parkinson Disease.

Authors:  Ana Canerina-Amaro; Daniel Pereda; Mario Diaz; Deiene Rodriguez-Barreto; Verónica Casañas-Sánchez; Marija Heffer; Paula Garcia-Esparcia; Isidro Ferrer; Ricardo Puertas-Avendaño; Raquel Marin
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

Review 3.  The Role of Lipids in Parkinson's Disease.

Authors:  Helena Xicoy; Bé Wieringa; Gerard J M Martens
Journal:  Cells       Date:  2019-01-07       Impact factor: 6.600

Review 4.  Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases.

Authors:  Sara Grassi; Laura Mauri; Simona Prioni; Livia Cabitta; Sandro Sonnino; Alessandro Prinetti; Paola Giussani
Journal:  Front Pharmacol       Date:  2019-07-23       Impact factor: 5.810

5.  More Favorable Palmitic Acid Over Palmitoleic Acid Modification of Wnt3 Ensures Its Localization and Activity in Plasma Membrane Domains.

Authors:  Yagmur Azbazdar; Ozgun Ozalp; Erdinc Sezgin; Sapthaswaran Veerapathiran; Anna L Duncan; Mark S P Sansom; Christian Eggeling; Thorsten Wohland; Ezgi Karaca; Gunes Ozhan
Journal:  Front Cell Dev Biol       Date:  2019-11-15

Review 6.  Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.

Authors:  Wei Mu; Zhe Wang; Margot Zöller
Journal:  Front Oncol       Date:  2019-12-16       Impact factor: 6.244

Review 7.  Sphingosine 1-Phosphate (S1P)/ S1P Receptor Signaling and Mechanotransduction: Implications for Intrinsic Tissue Repair/Regeneration.

Authors:  Chiara Sassoli; Federica Pierucci; Sandra Zecchi-Orlandini; Elisabetta Meacci
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

Review 8.  Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson's Disease.

Authors:  Joanna A Motyl; Joanna B Strosznajder; Agnieszka Wencel; Robert P Strosznajder
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

9.  Integrated Metabolomic and Lipidomic Analysis Reveals the Neuroprotective Mechanisms of Bushen Tiansui Formula in an Aβ1-42-Induced Rat Model of Alzheimer's Disease.

Authors:  Min Yi; Chunhu Zhang; Zheyu Zhang; Pengji Yi; Panpan Xu; Jianhua Huang; Weijun Peng
Journal:  Oxid Med Cell Longev       Date:  2020-06-19       Impact factor: 6.543

Review 10.  Contribution of Extracellular Vesicles in Rebuilding Injured Muscles.

Authors:  Daniel C Bittel; Jyoti K Jaiswal
Journal:  Front Physiol       Date:  2019-07-18       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.